在孕前症中,病理生理机制和分子标
Jinxuan Ren1, Mei Yang2, Qing Zhu2
1Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, NHC Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region "Hypertension Research Laboratory", Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, Xinjiang, People's Republic of China; Xinjiang Medical University, People's Republic of China.
孕前,一种影响全球2-8%的妊娠障碍,涉及胎盘问题和母亲的反应. 早期预测和向疗法显示出希望,但异质性和验证方面的挑战仍然存在.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 病理生理学 病理生理学
背景情况:
- 孕前是一种特定于怀孕的多系统疾病,具有显著的全球孕产妇和新生儿发病率/死亡率.
- 发病包括两个阶段:缺陷的早期胎盘 (缺血/缺氧) 和妊娠中后期的母体系统反应 (炎症,内皮功能障碍).
研究的目的:
- 审查近期预孕前预测,治疗和剩余挑战方面的进展.
- 突出多组和液体活检在生物标志物发现中的作用.
- 讨论针对关键病理途径的新兴治疗策略.
主要方法:
- 对目前关于孕前病原体,生物标志物和治疗方法的文献的综述.
- 分析多omics技术和液体活检应用.
- 检查新兴的治疗策略,包括肝素,补充抑制剂和表观遗传调节器.
主要成果:
- 通过先进技术,正在发现用于非侵入性早期预测的新生物标志物.
- 新兴疗法针对的是血管生成失衡,炎症和内皮功能障碍.
- 仍然存在重大挑战,包括疾病异质性和有限的临床验证.
结论:
- 未来的研究必须专注于精确的预测模型和针对性治疗的大规模临床试验.
- 综合性产后随访对于管理长期心血管后果至关重要.
- 改善预防,诊断和治疗需要解决当前的研究和临床差距.
更多相关视频
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
相关概念视频
Hormonal Regulation
Hypertension II: Pathophysiology
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hypertension and Regulation of Blood Pressure
Heart Failure II: Pathophysiology
